ARTICLE | Clinical News
NCX 701: Began Phase I trial
January 2, 2001 8:00 AM UTC
NicOx S.A. (NM:Nicox), Sophia-Antipolis, France Product: NCX 701 Business: Neurological, Autoimmune/Inflammation Therapeutic category: Analgesic, Nitric oxide Target: Cyclooxygenase enzymes Descripti...